Nurix

Senior Scientist, Analytical Development and Quality Control - Early Phase

Nurix$162K — $186K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Advanced degree in Chemistry, Pharmaceutics, or a related field
  • BS/MS with 14+ years or PhD with 8+ years of CMC experience
  • Strong background in drug product analytical development and validation
  • Experience in analytical methods for amorphous solid dispersions (ASDs) and lipid-based formulations
  • Proven track record in CDMO and contract testing lab oversight
  • Experience with regulatory submissions (IND, IMPD, NDA) and global filings
  • Fluency with ICH guidelines and cGMP standards

Responsibilities

  • Lead analytical method development and lifecycle management for drug product formulations
  • Support PPQ activities and commercial QC for analytical methods
  • Design and oversee developmental stability programs and trend analyses
  • Author and review reports to support regulatory submissions
  • Oversee analytical activities at external CDMOs and testing labs
  • Contribute to root cause investigations and CAPA processes
  • Perform reviews of analytical data, protocols, and related documentation
  • Trend stability data to establish retest periods and shelf life
  • Collaborate on material control strategies and specifications
  • Author technical documents for regulatory purposes
  • Act as a key contributor to multidisciplinary team projects
  • Organize analytical data for traceability and inspection readiness
  • Adhere to cGMP requirements and SOPs
  • Minimal travel up to 5% for duties

Benefits

  • Work in a collaborative cross-functional environment
  • Onsite position at Nurix headquarters in Brisbane, CA
  • Engagement in innovative oncology and immunology programs
  • Contribution to late-phase development and regulatory projects
  • Opportunity to influence drug product lifecycle management
Full Job Description
Position

Nurix Therapeutics seeks an experienced Senior Scientist to join the Analytical Development and Quality Control group. The Senior Scientist will be responsible for drug product (DP) analytical development, including method development, oversight of method validation at CDMOs, and lifecycle management in support of Nurix's oncology and inflammation & immunology (I&I) programs.

This position provides technical oversight of analytical method development, validation, and testing conducted at external CDMO/CRO partners. The Senior Scientist will author analytical development reports and IND/IMPD/NDA sections and support late-phase tech transfer and validation activities. This role will also contribute to analytical development for new drug products and dosage forms. The Senior Scientist will work closely in cross-functional teams to ensure alignment and integration of analytical and QC strategies across development stages.

The ideal candidate will have expertise in chromatographic and dissolution method development, stability studies, and phase-appropriate validation and control strategies, along with demonstrated experience supporting late-phase development and regulatory submissions.

This position is onsite at Nurix headquarters in Brisbane, CA.

Responsibilities:
  • Lead analytical method development validation and lifecycle management for drug product formulations, including amorphous solid dispersions (ASDs) and lipid-based systems
  • Support PPQ activities, commercialization, commercial QC, and lifecycle management for drug product analytical methods and control strategies
  • Design and oversee DP development, registration batch, and commercial stability programs, including protocol development and trend analysis
  • Author and review DP analytical development reports to support regulatory submissions, and marketing authorization
  • Oversee and support analytical activities, including method development, validation, and QC testing conducted at CDMOs and contract testing laboratories (CTLs)
  • Contribute to investigations (e.g., OOS, OOE, OOT), root cause analysis and CAPAs
  • Perform critical review of analytical data, protocols, reports, specifications, and related documentation
  • Trend stability data and support establishment of retest periods and shelf life using statistical methods
  • Collaborate in the development and justification of material control strategies and specifications
  • Author technical documents, including analytical development reports, specifications, validation and stability protocols/reports, certificates of analysis (COAs), and storage statements
  • Author and review analytical sections of regulatory submissions (e.g., IND/IMPD/NDA)
  • Collaboratively author responses to health authority requests for information
  • Act as a key contributor to multidisciplinary teams, including Chemical Development, Pharmaceutical Development, Regulatory, Quality, Preclinical, Supply Chain, Medicinal Chemistry, and DMPK
  • Maintain and organize analytical documentation and data to ensure traceability, data integrity, and inspection readiness
  • Follow cGMP requirements and internal SOPs
  • Travel up to 5%, as required

Qualifications:
  • Advanced degree in a relevant discipline (Chemistry, Pharmaceutics, or related field)
  • Senior Scientist: BS/MS degree with 14+ years or PhD with 8+ years of industrial CMC experience
  • Strong experience in drug product analytical development and validation
  • Experience with analytical development for amorphous solid dispersions (ASDs) and/or lipid-based formulations
  • Experience in CDMO and contract testing lab oversight
  • Experience supporting regulatory submissions (e.g., IND, IMPD, NDA) and global regulatory filings
  • Fluency with ICH guidelines, cGMPs, and pharmacopeial chapters
  • Ability to work effectively in a cross-functional environment
  • Strong technical writing skills (e.g., development reports, regulatory documents)
  • Ability to manage multiple priorities in a fast-paced environment
  • Excellent communication and cross-functional collaboration skills

Salary Range: $162K - $186K

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Senior Scientist, Analytical Development and Quality Control - Early Phase jobs: